Welcome to LookChem.com Sign In|Join Free

CAS

  • or

199339-71-4

Post Buying Request

199339-71-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

199339-71-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 199339-71-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,3,3 and 9 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 199339-71:
(8*1)+(7*9)+(6*9)+(5*3)+(4*3)+(3*9)+(2*7)+(1*1)=194
194 % 10 = 4
So 199339-71-4 is a valid CAS Registry Number.

199339-71-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Hydroxy-1-benzothiophene-7-carbaldehyde

1.2 Other means of identification

Product number -
Other names 4-hydroxy-benzo[b]thiophene-7-carboxaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:199339-71-4 SDS

199339-71-4Relevant articles and documents

Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes

-

Page/Page column 88; 89, (2015/07/07)

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) as follows: wherein R1, G, and Q are defined herein.

GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES

-

Paragraph 0858; 0859, (2014/09/30)

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) and Formula (II) as follows: wherein Y, R1, G, and Q are defined herein; and wherein R11, R21, R41, RB1 and G1, are defined herein.

Novel process for the preparation of the insulin sensitizer

-

Page 6, (2010/02/10)

A novel process for the preparation of compounds of formula I and optionally converting a compound of formula I into a pharmaceutically acceptable salt is disclosed. The compounds of formula I and the corresponding salts, e.g. the sodium salts, are pharma

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 199339-71-4